Purpose of this Study
We are doing this study to improve how patients and their primary care providers can keep up with routine health maintenance during cancer treatments. We want to know if a new model of communication between patients and their doctors can improve health outcomes.
Who Can Participate?
Eligibility
Adults ages 18-79 who have a primary care provider and are taking a medication for at least one of the following conditions:
- High blood pressure; OR
- Diabetes/high blood sugar; OR
- High cholesterol
- Stage I-III breast cancer (female only)
- Stage I-III colorectal cancer
- Stage I-III endometrial cancer
- Stage I-III head/neck cancer
- Stage I-III non-small cell lung cancer
- Stage I-IV prostate cancer
Age Range
18-59
Sex/Genders
Female (cisgender)
Non-binary or gender fluid
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, you will:
- Visit our clinic 4 times over the course of 18 months (6 months between each visit)
- Fill out surveys and answer questionnaires
- Have your blood pressure measured
- Have blood draws for testing
- One group will receive the current, standard educational materials about healthy living during cancer treatment and how to transition from cancer care to follow-up care (control group)
- The other group will receive the study intervention (study group)
- We will get in touch with your primary care provider to let them know that you are participating in this study
- A cancer physician will be in touch with your primary care provider to provide updates
- You will attend a live webinar to learn about the importance of managing your blood pressure, blood sugar, and cholesterol during and after cancer treatment
- We will send you a series of brief videos that discuss the importance of maintaining your cardiovascular health during cancer treatment
Locations
Remote/online
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Onco-primary care networking to support TEAM-based care – the ONE TEAM Study
Principal Investigator
Kevin
Oeffinger
Protocol Number
PRO00104179
NCT ID
NCT04258813
Phase
N/A
Enrollment Status
Open to Enrollment